📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Herantis Pharma

1.1 - Company Overview

Herantis Pharma Logo

Herantis Pharma

Headquarter: Finland
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of pharmaceutical therapies targeting unmet clinical needs, including HER-096, a small synthetic peptidomimetic based on the CDNF protein's active site for treating Parkinson’s disease, designed for subcutaneous administration and demonstrating good safety, tolerability, and efficient blood-brain barrier penetration in Phase 1a clinical trials.

Products and services

  • HER-096: A small synthetic chemical peptidomimetic molecule engineered from CDNF’s active site to treat Parkinson’s via subcutaneous administration, demonstrating good safety, tolerability, and efficient blood-brain barrier penetration in Phase 1a.

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Herantis Pharma

Dyax Logo

Dyax

HQ: United States Website
  • Description: Provider of biotherapeutics focused on the discovery, development and commercialization for unmet medical needs, with an emphasis on inflammatory and oncology indications; lead product DX-88 approved under the brand name KALBITOR (ecallantide) by the United States Food and Drug.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Dyax company profile →
Algernon Pharmaceuticals Logo

Algernon Pharmaceuticals

HQ: Canada Website
  • Description: Provider of pharmaceutical R&D, in-licensing, and commercialization, advancing NP-120 (Ifenprodil) investigated for chronic cough and idiopathic pulmonary fibrosis, NP-251 (Repirinast) repurposed for chronic kidney disease, and AP-188 (DMT), a naturally occurring psychedelic compound explored for stroke and traumatic brain injury.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Algernon Pharmaceuticals company profile →
Lanthiopharma Logo

Lanthiopharma

HQ: The Netherlands Website
  • Description: Provider of drug discovery focused on therapeutic lantipeptide drugs for serious diseases, applying proprietary lanthionine-peptide technology (LanthioPepTM) to generate novel peptide therapeutics with increased resistance to peptidase degradation, high receptor specificity and increased intrinsic activity.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Lanthiopharma company profile →
PharmAkea Logo

PharmAkea

HQ: United States Website
  • Description: Provider of biopharmaceutical R&D, developing high-quality small molecule drug candidates against protein targets involved in fibroproliferative diseases.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full PharmAkea company profile →
AM-Pharma Logo

AM-Pharma

HQ: The Netherlands Website
  • Description: Provider of biopharmaceutical therapeutics focused on inflammatory and infectious diseases, developing and commercializing products based on endogenous proteins, including ilofotase alfa, a recombinant alkaline phosphatase under development to prevent cardiac surgery-associated renal damage and as enzyme replacement therapy for hypophosphatasia.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full AM-Pharma company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Herantis Pharma

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Herantis Pharma

2.2 - Growth funds investing in similar companies to Herantis Pharma

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Herantis Pharma

4.2 - Public trading comparable groups for Herantis Pharma

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Herantis Pharma

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Herantis Pharma

What does Herantis Pharma do?

Herantis Pharma is a provider of pharmaceutical therapies targeting unmet clinical needs, including HER-096, a small synthetic peptidomimetic based on the CDNF protein's active site for treating Parkinson’s disease, designed for subcutaneous administration and demonstrating good safety, tolerability, and efficient blood-brain barrier penetration in Phase 1a clinical trials.

Who are Herantis Pharma's competitors?

Herantis Pharma's competitors and similar companies include Dyax, Algernon Pharmaceuticals, Lanthiopharma, PharmAkea, and AM-Pharma.

Where is Herantis Pharma headquartered?

Herantis Pharma is headquartered in Finland.

How many employees does Herantis Pharma have?

Herantis Pharma has 1,000 employees 🔒.

When was Herantis Pharma founded?

Herantis Pharma was founded in 2010 🔒.

What sector and industry vertical is Herantis Pharma in?

Herantis Pharma is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Herantis Pharma

Who are the top strategic acquirers in Herantis Pharma's sector and industry

Top strategic M&A buyers and acquirers in Herantis Pharma's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Herantis Pharma?

Top strategic M&A buyers groups and sectors for Herantis Pharma include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Herantis Pharma's sector and industry vertical

Which are the top PE firms investing in Herantis Pharma's sector and industry vertical?

Top PE firms investing in Herantis Pharma's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Herantis Pharma's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Herantis Pharma's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Herantis Pharma's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Herantis Pharma include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Herantis Pharma's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Herantis Pharma?

The key public trading comparables and valuation benchmarks for Herantis Pharma include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Herantis Pharma for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Herantis Pharma with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Herantis Pharma's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Herantis Pharma with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Herantis Pharma's' sector and industry vertical?

Access recent funding rounds and capital raises in Herantis Pharma's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Herantis Pharma